Skip to main content
Local News

CAR T-Cell Therapy Is the Leading Edge of Care for Post-Transplant Lymphoproliferative Disorder

By June 28, 2023No Comments

Fred Hutchinson Cancer Center is home to some of the world’s most advanced cancer treatments, including CAR T-cell therapy for post-transplant lymphoproliferative disorder (PTLD). Physicians in the Cancer and Organ Transplant Clinic (COTC) at Fred Hutch recently published a report of a patient who became the 17th in the world to receive this life-saving therapy.

Physicians of COTC successfully used CAR T-cell therapy to treat a patient with PTLD. The 47-year old patient, who had three kidney transplants over 34 years, was the 17th in the world to receive this innovative treatment. A case report and systematic review, published recently in Bone Marrow Transplantation, details the treatment and positive outcomes.